HBA1 and autoimmune disease: In contrast, for the patients in the treatment sensitive group, indicators including age, course, allodynia, pain area, coexistence of diabetes mellitus, autoimmune diseases, tumors, use of immunosuppressants, hemoglobin, monocyte count, HbA1, antiviral drug use, and compliance showed significant correlations with those in the treatment insensitive group (p < 0.05) (Table 1).